Profile data is unavailable for this security.
About the company
NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ExoTherapy production platform and products for a global market. It is involved in the development of ExoPTEN, the first ExoTherapy-based product for acute Spinal Cord Injuries (SCI). The Company is developing treatment for the reversal or reduction of paralysis following spinal cord injury (SCI) using Exosomes (membrane-bound extracellular vesicles). This technology, subject to conducting clinical trials and receiving Food and Drug Administration (the FDA) approval, can be used in various conditions such as SCI, Brain Trauma Injury (BTI), and potentially other brain and neurological indications.
- Revenue in CAD (TTM)0.00
- Net income in CAD-5.68m
- Incorporated2011
- Employees8.00
- LocationNurexone Biologic Inc9 Mezada Street, Bsr 3 Tower, 30 FloorBNEI BRAK 5120109IsraelISR
- Phone+1 4 164105297
- Fax+1 4 164105297
- Websitehttps://nurexone.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COSCIENS Biopharma Inc | 6.19m | -17.28m | 19.04m | 21.00 | -- | 0.4385 | -- | 3.07 | -12.83 | -12.83 | 3.66 | 11.74 | 0.0936 | 1.74 | 6.35 | -- | -26.11 | -26.24 | -30.53 | -30.34 | 39.42 | 83.68 | -278.95 | -300.31 | 3.05 | -- | 0.0604 | -- | -20.25 | -30.06 | 27.17 | -- | 16.12 | -- |
Sirona Biochem Corp | -16.37k | -2.67m | 19.50m | -- | -- | -- | -- | -- | -0.0105 | -0.0105 | -0.00006 | -0.0134 | -0.0171 | -- | 1.61 | -- | -278.90 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -5.73 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
Thiogenesis Therapeutics Corp | 0.00 | -4.49m | 30.62m | -- | -- | 6.41 | -- | -- | -0.1092 | -0.1092 | 0.00 | 0.1045 | 0.00 | -- | -- | -- | -91.94 | -- | -98.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Avicanna Inc | 24.87m | -7.44m | 35.98m | 38.00 | -- | 996.92 | -- | 1.45 | -0.0804 | -0.0804 | 0.2714 | 0.0003 | 1.20 | 2.95 | 9.32 | 654,600.00 | -35.85 | -67.17 | -267.70 | -167.73 | 48.66 | 46.36 | -29.90 | -368.82 | 0.3316 | -8.88 | 0.1645 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
Nurexone Biologic Inc | 0.00 | -5.68m | 38.02m | 8.00 | -- | 10.65 | -- | -- | -0.1093 | -0.1093 | 0.00 | 0.0526 | 0.00 | -- | -- | -- | -183.97 | -213.78 | -235.34 | -596.97 | -- | -- | -- | -- | -- | -187.27 | 0.0096 | -- | -- | -- | 55.45 | -- | -- | -- |
Briacell Therapeutics Corp | 0.00 | -8.22m | 46.08m | 11.00 | -- | -- | -- | -- | -0.5365 | -0.5365 | 0.00 | -0.5117 | 0.00 | -- | -- | 0.00 | -33.97 | -59.37 | -43.50 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
Microbix Biosystems Inc | 23.36m | 5.08m | 47.02m | 69.00 | 9.34 | 1.68 | 7.13 | 2.01 | 0.0369 | 0.0369 | 0.1695 | 0.205 | 0.6488 | 1.63 | 6.35 | -- | 14.10 | -0.9729 | 16.10 | -1.17 | 57.21 | 52.30 | 21.73 | -1.55 | 4.89 | 5.93 | 0.1849 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
KDA Group Inc | 204.14k | -876.18k | 51.13m | -- | -- | 3.53 | -- | 250.46 | -0.0027 | 0.0783 | 0.0013 | 0.0821 | 0.008 | -- | 0.0835 | -- | -4.63 | -17.96 | -8.47 | -44.69 | 33.32 | 26.76 | -574.97 | -28.00 | -- | -7.08 | 0.0606 | -- | -22.20 | -62.03 | 106.88 | -- | 31.67 | -- |
Helix Biopharma Corp. | 0.00 | -6.14m | 53.19m | 9.00 | -- | -- | -- | -- | -0.1478 | -0.1478 | 0.00 | -0.0079 | 0.00 | -- | -- | 0.00 | -449.73 | -261.49 | -2,225.00 | -- | -- | -- | -- | -- | -- | -265.96 | -- | -- | -- | -- | 4.16 | -- | -28.36 | -- |